Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy

다국어 초록 (Multilingual Abstract)

Purpose The purpose of this study was to compare the clinical and functional outcomes in patients with primary base of tongue (BOT) cancer who received definitive radiotherapy (RT) or surgery followed by radiotherapy (SRT).
Materials and Methods Between January 2002 and December 2016, 102 patients with stage I-IVB primary BOT cancer underwent either definitive RT (n=46) or SRT (n=56), and treatment outcomes were compared between two groups. The expression of p16 was also analyzed.
Results The RT group had more patients with advanced T stage (T3-4) disease (58.7% vs. 35.7%, p=0.021) and who received chemotherapy (91.3% vs. 37.5%, p < 0.001) than the SRT group. At a median follow up of 36.9 months (range, 3.3 to 181.5 months), the 5-year overall survival (OS) and disease-free survival (DFS) were 75.5% and 68.7%, respectively. With respect to treatment group, the 5-year OS and DFS in the RT and SRT groups did not differ significantly (OS, 68.7% vs. 80.5%, p=0.601; DFS, 63.1% vs. 73.1%, p=0.653). In multivariate analysis, OS differed significantly according to p16 expression (p16-negative vs. p16- positive; hazard ratio [HR], 0.145; 95% confidence interval [CI], 0.025 to 0.853; p=0.033).
Regarding DFS, p16 expression (p16-negative vs. p16-positive; HR, 0.164; 95% CI, 0.045 to 0.598; p=0.006) showed a significant effect in multivariate analysis. Functional defects (late grade  3 dysphagia or voice alteration) were more frequently reported in the SRT than in the RT group (16.1% vs. 2.2%, p=0.021).
Conclusion Despite advanced disease, patients in the RT group showed comparable survival outcomes and better functional preservation than those in the SRT group.

참고문헌 (Reference)

1 Steiner W, "Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue" 129 : 36-43, 2003

2 Mydlarz WK, "The role of surgery for HPV-associated head and neck cancer" 51 : 305-313, 2015

3 Attner P, "The role of human papillomavirus in the increased incidence of base of tongue cancer" 126 : 2879-2884, 2010

4 Parsons JT, "Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both" 94 : 2967-2980, 2002

5 Peltenburg LT, "Radiosensitivity of tumor cells: oncogenes and apoptosis" 44 : 355-364, 2000

6 Kerr P, "Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy" 44 : 17-, 2015

7 Bernier J, "Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer" 350 : 1945-1952, 2004

8 Cooper JS, "Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck" 350 : 1937-1944, 2004

9 van Loon JW, "Outcome of transoral robotic surgery for stage I-II oropharyngeal cancer" 272 : 175-183, 2015

10 Kanakamedala M, "Outcome analysis of squamous cell carcinomas of oropharynx based on primary site that were treated with definitive intensity modulated radiation therapy concurrently with chemotherapy" 96 : 2016

11 Fein DA, "Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience" 34 : 289-296, 1996

12 Fischer CA, "Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?" 126 : 1256-1262, 2010

13 Mendenhall WM, "Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue?" 18 : 35-42, 2000

14 Licitra L, "High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma" 24 : 5630-5636, 2006

15 Marur S, "HPV-associated head and neck cancer: a virus-related cancer epidemic" 11 : 781-789, 2010

16 Denis F, "Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma" 22 : 69-76, 2004

17 Hinerman RW, "External beam irradiation alone or combined with neck dissection for base of tongue carcinoma: an alternative to primary surgery" 104 : 1466-1470, 1994

18 Pytynia KB, "Epidemiology of HPV-associated oropharyngeal cancer" 50 : 380-386, 2014

19 Karakoyun-Celik O, "Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base" 27 : 353-361, 2005

20 Mendenhall WM, "Definitive radiotherapy for squamous cell carcinoma of the base of tongue" 29 : 32-39, 2006

21 Lorincz BB, "Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective" 38 (38): E2190-E2196, 2016

22 Lawson JD, "Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base" 30 : 327-335, 2008

23 Forastiere AA, "Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer" 349 : 2091-2098, 2003

24 Machtay M, "Combined surgery and postoperative radiotherapy for carcinoma of the base of radiotherapy for carcinoma of the base of tongue: analysis of treatment outcome and prognostic value of margin status" 19 : 494-499, 1997

25 Reimers N, "Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer" 120 : 1731-1738, 2007

26 Brunin F, "Cancer of the base of the tongue: past and future" 21 : 751-759, 1999

27 Sessions DG, "Analysis of treatment results for base of tongue cancer" 113 : 1252-1261, 2003

28 Shi A, "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensitymodulated radiotherapy" 5 : 35-, 2010

29 Adelstein DJ, "An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer" 21 : 92-98, 2003